Shared on 19 May 26

Fair value Decreased 0.95%

EBO: Index Removal And Discount Rate Shift Will Support Capital Efficiency Reassessment

EBOS drops out of a major Australian share index, which could change how big funds buy and sell the stock. Analysts also tweak their assumptions about future performance and risk, nudging down their view of what the shares are worth.

45 views

Shared on 24 Apr 26

Fair value Decreased 0.91%

EBO: Index Removal And Higher Future P/E Will Support Capital Efficiency Reassessment

Analysts have trimmed their EBOS Group price target slightly from about NZ$33.94 to around NZ$33.63, reflecting updated assumptions for revenue growth, profit margins, and a modestly higher future P/E multiple. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which may influence how some index and rules based funds treat the shares (Key Developments).

23 views

Shared on 09 Apr 26

Fair value Increased 1.04%

EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment

Analysts have nudged their fair value estimate for EBOS Group to NZ$33.94 from NZ$33.59, reflecting slightly updated assumptions for long term profit margins and future P/E multiples, while keeping revenue growth and discount rate broadly unchanged. What's in the News EBOS Group Limited was removed from the S&P/ASX 200 Index, which can affect how some index funds and benchmark aware investors are exposed to the stock (Key Developments).

30 views

Shared on 25 Mar 26

Fair value Increased 0.099%

EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment

Analysts have made a small upward adjustment to EBOS Group's fair value estimate, with the price target moving from around NZ$33.56 to NZ$33.59 as they fine tune assumptions on long term profitability and the future P/E multiple. What's in the News EBOS Group Limited was dropped from the S&P/ASX 200 Index, which may affect index fund ownership and trading volumes for the stock (Key Developments).

20 views

Shared on 11 Mar 26

Fair value Decreased 4.72%

EBO: Updated Profit Outlook Will Support Future Capital Efficiency Reassessment

Analysts have trimmed their NZ$ fair value estimate for EBOS Group from NZ$35.22 to NZ$33.56, reflecting updated assumptions for slightly lower revenue growth, a more modest profit margin profile, and a similar forward P/E multiple. What's in the News EBOS Group held an Analyst/Investor Day, which provided an opportunity for management to update the market on the business and the outlook assumptions that feed into valuation work (Key Developments).

18 views

Shared on 25 Feb 26

EBO: Lower Forward P/E Reset Will Support Future Capital Efficiency Reassessment

Analysts have trimmed their forward P/E expectations for EBOS Group, prompting a reset in their NZ$ price targets while keeping fair value, revenue growth and profit margin assumptions broadly unchanged. What's in the News EBOS Group held an Analyst/Investor Day, giving the market an updated view on its business outlook, capital allocation priorities and key operating segments (Key Developments).

23 views

Shared on 11 Feb 26

Fair value Increased 0.57%

EBO: Analyst Day Will Support Future Capital Efficiency Reassessment

Analysts have nudged their fair value estimate for EBOS Group higher from A$35.02 to A$35.22, citing updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News EBOS Group held an Analyst/Investor Day, providing management with a forum to outline its business priorities and respond to questions from the investment community (Key Developments).

24 views

Shared on 27 Jan 26

Fair value Decreased 1.01%

EBO: Disciplined Bolt On Acquisitions Will Support Future Capital Efficiency

Analysts have modestly adjusted their fair value estimate for EBOS Group to A$35.02 from A$35.38, reflecting fine tuning to revenue growth, profit margin, and future P/E assumptions. What's in the News EBOS Group Limited is scheduled to host an Analyst/Investor Day, giving the market a closer look at its current operations and priorities (Key Developments).

30 views

Shared on 13 Jan 26

Fair value Increased 8.39%

EBO: Distribution Centre Renewal Program Will Support Future Capital Efficiency

Analysts have lifted their fair value estimate for EBOS Group from A$32.64 to A$35.38, citing updated assumptions around revenue growth, profit margins and the future P/E multiple as key drivers of the higher target. What's in the News EBOS Group plans to continue pursuing disciplined bolt on acquisitions, with Chair Elizabeth Coutts stating that the company aims to use these deals to support sustainable growth and create value for shareholders.

57 views

Shared on 18 Oct 25

Fair value Decreased 12%

Analysts have revised their price target for EBOS Group downward from $36.96 to $32.64. This adjustment is due to lowered revenue growth expectations, while profit margins and discount rates remain stable.

41 views

Shared on 17 Sep 25

Fair value Decreased 2.62%

EBOS Group’s consensus price target has been revised downward as a result of an increased future P/E ratio without a meaningful improvement in revenue growth expectations, reducing the fair value estimate from NZ$37.96 to NZ$36.96. What's in the News EBOS Group announced a supplementary dividend distribution of NZD 0.02713235 for the six months ended June 30, 2026; record date is 5 September, ex-date is 4 September, and payment date is 24 September.

31 views

Shared on 28 Aug 25

Fair value Decreased 3.96%

A slight rise in EBOS Group’s future P/E ratio, with virtually unchanged revenue growth forecasts, suggests increased valuation multiples underpin a marginal decrease in the consensus analyst price target from NZ$39.53 to NZ$38.95. Valuation Changes Summary of Valuation Changes for EBOS Group The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from NZ$39.53 to NZ$38.95.

9 views

Shared on 01 May 25

Fair value Decreased 3.41%

2 views

Shared on 23 Apr 25

Fair value Increased 1.54%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

3 views

Shared on 17 Apr 25

Fair value Increased 0.72%

AnalystConsensusTarget has increased revenue growth from 3.6% to 4.1%.

1 view

Shared on 09 Apr 25

Fair value Increased 0.65%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 02 Apr 25

Fair value Decreased 1.90%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

1 view

Shared on 26 Mar 25

Fair value Decreased 0.52%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

2 views

Shared on 19 Mar 25

Fair value Increased 1.94%

AnalystConsensusTarget has decreased revenue growth from 4.1% to 3.3%.

2 views

Shared on 12 Mar 25

Fair value Decreased 0.73%

1 view

Renewed Distribution And Digital Adoption Will Improve Healthcare Supply Chains

EBO: Index Removal And Discount Rate Shift Will Support Capital Efficiency Reassessment

EBO: Index Removal And Higher Future P/E Will Support Capital Efficiency Reassessment

EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment

EBO: Index Removal And P/E Outlook Will Support Future Capital Efficiency Reassessment

EBO: Updated Profit Outlook Will Support Future Capital Efficiency Reassessment

EBO: Lower Forward P/E Reset Will Support Future Capital Efficiency Reassessment

EBO: Analyst Day Will Support Future Capital Efficiency Reassessment

EBO: Disciplined Bolt On Acquisitions Will Support Future Capital Efficiency

EBO: Distribution Centre Renewal Program Will Support Future Capital Efficiency

Shared on 18 Oct 25

Shared on 17 Sep 25

Shared on 28 Aug 25

Shared on 01 May 25

Shared on 23 Apr 25

Shared on 17 Apr 25

Shared on 09 Apr 25

Shared on 02 Apr 25

Shared on 26 Mar 25

Shared on 19 Mar 25

Shared on 12 Mar 25